These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 30503553)

  • 1. MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma development by targeting CCDC6.
    Jia M; Shi Y; Li Z; Lu X; Wang J
    Cancer Lett; 2019 Feb; 443():145-156. PubMed ID: 30503553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting
    Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L
    Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634
    [No Abstract]   [Full Text] [Related]  

  • 3. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
    Peng Y; Fang X; Yao H; Zhang Y; Shi J
    Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
    [No Abstract]   [Full Text] [Related]  

  • 4. The circ_FAM53B-miR-183-5p-CCDC6 axis modulates the malignant behaviors of papillary thyroid carcinoma cells.
    Zhang C; Gu H; Liu D; Tong F; Wei H; Zhou D; Fang J; Dai X; Tian H
    Mol Cell Biochem; 2022 Nov; 477(11):2627-2641. PubMed ID: 35598218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.
    Lima CR; Geraldo MV; Fuziwara CS; Kimura ET; Santos MF
    BMC Cancer; 2016 Feb; 16():108. PubMed ID: 26883911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of the human major histocompatibility complex class I chain-related gene A (MICA) and its receptor is mediated by microRNA-146b-5p and is a potential mechanism of immunoediting in papillary thyroid carcinoma.
    Al-Abdallah A; Jahanbani I; Mehdawi H; Ali RH; Al-Brahim N; Mojiminiyi O; Junaid TA
    Exp Mol Pathol; 2020 Apr; 113():104379. PubMed ID: 31935378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR-146b-5p via iodine involvement repressed papillary thyroid carcinoma cell proliferation.
    Pan Y; Yun W; Shi B; Cui R; Liu C; Ding Z; Fan J; Jiang W; Tang J; Zheng T; Yu X; Liu Y
    J Mol Endocrinol; 2020 Aug; 65(2):1-10. PubMed ID: 32302969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stress-activated protein kinase pathway and the expression of stanniocalcin-1 are regulated by miR-146b-5p in papillary thyroid carcinogenesis.
    Al-Abdallah A; Jahanbani I; Mehdawi H; Ali RH; Al-Brahim N; Mojiminiyi O
    Cancer Biol Ther; 2020 May; 21(5):412-423. PubMed ID: 32037949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.
    Chou CK; Chi SY; Huang CH; Chou FF; Huang CC; Liu RT; Kang HY
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4357-4366. PubMed ID: 27533309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
    Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
    Chen N; Yin D; Lun B; Guo X
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways.
    Li C; Zhu L; Fu L; Han M; Li Y; Meng Z; Qiu X
    Diagn Pathol; 2021 Oct; 16(1):93. PubMed ID: 34689819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
    Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
    Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3.
    Deng X; Wu B; Xiao K; Kang J; Xie J; Zhang X; Fan Y
    Cell Physiol Biochem; 2015; 35(1):71-82. PubMed ID: 25547151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
    Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis.
    Li G; Kong Q
    Biol Res; 2019 Dec; 52(1):61. PubMed ID: 31870440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma.
    Czajka AA; Wójcicka A; Kubiak A; Kotlarek M; Bakuła-Zalewska E; Koperski Ł; Wiechno W; Jażdżewski K
    PLoS One; 2016; 11(3):e0151968. PubMed ID: 27011326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
    Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
    J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.